Quick Answer
ACRO BIOMEDICAL CO., LTD. reported Net Income of -$101.1 thousand for fiscal year 2025.
ACRO BIOMEDICAL CO., LTD. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$101.1K | -139.1% |
| 2024 | -$42.3K | +99.5% |
| 2023 | -$8.81M | +44.5% |
| 2022 | -$15.87M | -106.2% |
| 2021 | -$7.70M | -6454.0% |
| 2020 | -$117.5K | +68.4% |
| 2019 | -$371.6K | -0.2% |
| 2019 | -$370.7K | -188.3% |
| 2018 | $419.7K | +18768.1% |
| 2017 | -$2.2K | +94.8% |
| 2016 | -$43.4K | +8.6% |
| 2015 | -$47.5K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$117.8K | -1051.7% | -657.0% |
| June 30, 2025 | -$15.6K | -53.4% | -51.1% |
| March 31, 2025 | -$10.3K | +8.5% | -0.7% |
| September 30, 2024 | -$10.2K | +99.4% | -0.8% |
| June 30, 2024 | -$10.1K | +99.7% | +9.9% |
| March 31, 2024 | -$11.3K | +99.7% | +99.3% |
| September 30, 2023 | -$1.59M | +60.4% | +50.3% |
| June 30, 2023 | -$3.20M | +20.0% | +20.2% |
- ACRO BIOMEDICAL CO., LTD. showed a decrease of -139.1% in Net Income compared to the prior fiscal year.
- Over the 2015–2025 period, ACRO BIOMEDICAL CO., LTD.’s net income has declined by 113.0% (from -$47.5 thousand to -$101.1 thousand).
- The most recent figure is from ACRO BIOMEDICAL CO., LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: